Container system for enabling commercial production of cryopreserved cell therapy products

Erik J. Woods, Aniruddha Bagchi, W. Goebel, Vinod D. Vilivalam

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Aim: The expansion of cellular therapeutics will require large-scale manufacturing processes to expand and package cell products, which may not be feasible with current blood-banking bag technology. This study investigated the potential for freezing, storing and shipping cell therapy products using novel pharmaceutical-grade Crystal Zenith® (CZ) plastic vials. Materials & methods: CZ vials (0.5, 5 and 30 ml volume) with several closure systems were filled with mesenchymal stem cells and stored at either -85 or -196°C for 6 months. Vials were tested for their ability to maintain cell viability, proliferative and differentiation capacity, as well as durability and integrity utilizing a 1-m drop test. As controls, 2 ml polypropylene vials were investigated under the same conditions. Results: Post-thaw viability utilizing a dye exclusion assay was over 95% in all samples. Stored cells exhibited rapid recovery 2 h post-thaw and cultures were approximately 70% confluent within 5-7 days, consistent with nonfrozen controls and indicative of functional recovery. Doubling times were consistent over all vials. The doubling rate for cells from CZ vials were 2.14 ± 0.83 days (1 week), 1.84 ± 0.68 days (1 month) and 1.79 ± 0.71 days (6 months), which were not significantly different compared with frozen and fresh controls. Cells recovered from the vials exhibited trilineage differentiation consistent with controls. As part of vial integrity via drop testing, no evidence of external damage was found on vial surfaces or on closure systems. Furthermore, the filled vials stored for 6 months were tested for container closure integrity. Vials removed from freezer conditions were transported to the test laboratory on dry ice and tested using pharmaceutical packaging tests, including dye ingress and microbial challenge. The results of all stoppered vials indicated container closure integrity with no failures. Conclusion: Pharmaceutical-grade plastic CZ vials, which are commercially used to package pharmaceutical products, are suitable for low-temperature storage and transport of mesenchymal stem cells, and are a scalable container system for commercial manufacturing and fill-finish operation of cell therapy products.

Original languageEnglish
Pages (from-to)659-667
Number of pages9
JournalRegenerative Medicine
Volume5
Issue number4
DOIs
StatePublished - Jul 2010

Fingerprint

Cell- and Tissue-Based Therapy
Drug products
Containers
Container closures
Crystals
Stem cells
Mesenchymal Stromal Cells
Pharmaceutical Preparations
Plastics
Coloring Agents
Dyes
Dry Ice
Recovery
Blood Banks
Polypropylenes
Product Packaging
Freight transportation
Freezing
Ice
Cell Differentiation

Keywords

  • cryopreservation
  • fill finish
  • manufacturing
  • packaging
  • scaleable
  • stem cells
  • vials

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

Container system for enabling commercial production of cryopreserved cell therapy products. / Woods, Erik J.; Bagchi, Aniruddha; Goebel, W.; Vilivalam, Vinod D.

In: Regenerative Medicine, Vol. 5, No. 4, 07.2010, p. 659-667.

Research output: Contribution to journalArticle

Woods, Erik J. ; Bagchi, Aniruddha ; Goebel, W. ; Vilivalam, Vinod D. / Container system for enabling commercial production of cryopreserved cell therapy products. In: Regenerative Medicine. 2010 ; Vol. 5, No. 4. pp. 659-667.
@article{7c0cb17901dc473aa1af2fad4d87baff,
title = "Container system for enabling commercial production of cryopreserved cell therapy products",
abstract = "Aim: The expansion of cellular therapeutics will require large-scale manufacturing processes to expand and package cell products, which may not be feasible with current blood-banking bag technology. This study investigated the potential for freezing, storing and shipping cell therapy products using novel pharmaceutical-grade Crystal Zenith{\circledR} (CZ) plastic vials. Materials & methods: CZ vials (0.5, 5 and 30 ml volume) with several closure systems were filled with mesenchymal stem cells and stored at either -85 or -196°C for 6 months. Vials were tested for their ability to maintain cell viability, proliferative and differentiation capacity, as well as durability and integrity utilizing a 1-m drop test. As controls, 2 ml polypropylene vials were investigated under the same conditions. Results: Post-thaw viability utilizing a dye exclusion assay was over 95{\%} in all samples. Stored cells exhibited rapid recovery 2 h post-thaw and cultures were approximately 70{\%} confluent within 5-7 days, consistent with nonfrozen controls and indicative of functional recovery. Doubling times were consistent over all vials. The doubling rate for cells from CZ vials were 2.14 ± 0.83 days (1 week), 1.84 ± 0.68 days (1 month) and 1.79 ± 0.71 days (6 months), which were not significantly different compared with frozen and fresh controls. Cells recovered from the vials exhibited trilineage differentiation consistent with controls. As part of vial integrity via drop testing, no evidence of external damage was found on vial surfaces or on closure systems. Furthermore, the filled vials stored for 6 months were tested for container closure integrity. Vials removed from freezer conditions were transported to the test laboratory on dry ice and tested using pharmaceutical packaging tests, including dye ingress and microbial challenge. The results of all stoppered vials indicated container closure integrity with no failures. Conclusion: Pharmaceutical-grade plastic CZ vials, which are commercially used to package pharmaceutical products, are suitable for low-temperature storage and transport of mesenchymal stem cells, and are a scalable container system for commercial manufacturing and fill-finish operation of cell therapy products.",
keywords = "cryopreservation, fill finish, manufacturing, packaging, scaleable, stem cells, vials",
author = "Woods, {Erik J.} and Aniruddha Bagchi and W. Goebel and Vilivalam, {Vinod D.}",
year = "2010",
month = "7",
doi = "10.2217/rme.10.41",
language = "English",
volume = "5",
pages = "659--667",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Container system for enabling commercial production of cryopreserved cell therapy products

AU - Woods, Erik J.

AU - Bagchi, Aniruddha

AU - Goebel, W.

AU - Vilivalam, Vinod D.

PY - 2010/7

Y1 - 2010/7

N2 - Aim: The expansion of cellular therapeutics will require large-scale manufacturing processes to expand and package cell products, which may not be feasible with current blood-banking bag technology. This study investigated the potential for freezing, storing and shipping cell therapy products using novel pharmaceutical-grade Crystal Zenith® (CZ) plastic vials. Materials & methods: CZ vials (0.5, 5 and 30 ml volume) with several closure systems were filled with mesenchymal stem cells and stored at either -85 or -196°C for 6 months. Vials were tested for their ability to maintain cell viability, proliferative and differentiation capacity, as well as durability and integrity utilizing a 1-m drop test. As controls, 2 ml polypropylene vials were investigated under the same conditions. Results: Post-thaw viability utilizing a dye exclusion assay was over 95% in all samples. Stored cells exhibited rapid recovery 2 h post-thaw and cultures were approximately 70% confluent within 5-7 days, consistent with nonfrozen controls and indicative of functional recovery. Doubling times were consistent over all vials. The doubling rate for cells from CZ vials were 2.14 ± 0.83 days (1 week), 1.84 ± 0.68 days (1 month) and 1.79 ± 0.71 days (6 months), which were not significantly different compared with frozen and fresh controls. Cells recovered from the vials exhibited trilineage differentiation consistent with controls. As part of vial integrity via drop testing, no evidence of external damage was found on vial surfaces or on closure systems. Furthermore, the filled vials stored for 6 months were tested for container closure integrity. Vials removed from freezer conditions were transported to the test laboratory on dry ice and tested using pharmaceutical packaging tests, including dye ingress and microbial challenge. The results of all stoppered vials indicated container closure integrity with no failures. Conclusion: Pharmaceutical-grade plastic CZ vials, which are commercially used to package pharmaceutical products, are suitable for low-temperature storage and transport of mesenchymal stem cells, and are a scalable container system for commercial manufacturing and fill-finish operation of cell therapy products.

AB - Aim: The expansion of cellular therapeutics will require large-scale manufacturing processes to expand and package cell products, which may not be feasible with current blood-banking bag technology. This study investigated the potential for freezing, storing and shipping cell therapy products using novel pharmaceutical-grade Crystal Zenith® (CZ) plastic vials. Materials & methods: CZ vials (0.5, 5 and 30 ml volume) with several closure systems were filled with mesenchymal stem cells and stored at either -85 or -196°C for 6 months. Vials were tested for their ability to maintain cell viability, proliferative and differentiation capacity, as well as durability and integrity utilizing a 1-m drop test. As controls, 2 ml polypropylene vials were investigated under the same conditions. Results: Post-thaw viability utilizing a dye exclusion assay was over 95% in all samples. Stored cells exhibited rapid recovery 2 h post-thaw and cultures were approximately 70% confluent within 5-7 days, consistent with nonfrozen controls and indicative of functional recovery. Doubling times were consistent over all vials. The doubling rate for cells from CZ vials were 2.14 ± 0.83 days (1 week), 1.84 ± 0.68 days (1 month) and 1.79 ± 0.71 days (6 months), which were not significantly different compared with frozen and fresh controls. Cells recovered from the vials exhibited trilineage differentiation consistent with controls. As part of vial integrity via drop testing, no evidence of external damage was found on vial surfaces or on closure systems. Furthermore, the filled vials stored for 6 months were tested for container closure integrity. Vials removed from freezer conditions were transported to the test laboratory on dry ice and tested using pharmaceutical packaging tests, including dye ingress and microbial challenge. The results of all stoppered vials indicated container closure integrity with no failures. Conclusion: Pharmaceutical-grade plastic CZ vials, which are commercially used to package pharmaceutical products, are suitable for low-temperature storage and transport of mesenchymal stem cells, and are a scalable container system for commercial manufacturing and fill-finish operation of cell therapy products.

KW - cryopreservation

KW - fill finish

KW - manufacturing

KW - packaging

KW - scaleable

KW - stem cells

KW - vials

UR - http://www.scopus.com/inward/record.url?scp=77954805660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954805660&partnerID=8YFLogxK

U2 - 10.2217/rme.10.41

DO - 10.2217/rme.10.41

M3 - Article

C2 - 20632866

AN - SCOPUS:77954805660

VL - 5

SP - 659

EP - 667

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 4

ER -